Xiaoling Yan

122 QiXiangTai Road
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Molecular alterations prediction in gliomas via an interpretable deep learning model: a multicentre and retrospective study.

Molecular alterations prediction in gliomas via an interpretable deep learning model: a multicentre and retrospective study.

Journal: The Lancet. Digital health

Published: July 09, 2025

Pathological findings from surgical specimens and long-term outcome in cerebral amyloid angiopathy patients with intracerebral hemorrhage.

Pathological findings from surgical specimens and long-term outcome in cerebral amyloid angiopathy patients with intracerebral hemorrhage.

Journal: Scientific reports

Published: June 09, 2025

Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics.

Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics.

Journal: Heliyon

Published: May 28, 2024

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.

Journal: Scientific reports

Published: September 30, 2022

RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.

RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.

Journal: Cell death & disease

Published: February 01, 2020

Rapid intraoperative immunocytochemistry of central nervous system tumors.

Rapid intraoperative immunocytochemistry of central nervous system tumors.

Journal: International journal of clinical and experimental pathology

Published: November 09, 2019

Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification.

Clinicopathological analysis of 250 cases of pituitary adenoma under the new WHO classification.

Journal: Oncology letters

Published: May 22, 2019

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.

Journal: OncoTargets and therapy

Published: March 10, 2018

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI-derived and clinical features, predict adult primary glioblastoma survival.

Journal: Cancer medicine

Published: February 26, 2018

Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.

Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma.

Journal: Journal of molecular neuroscience : MN

Published: January 04, 2018

Significance of TERT and ATRX mutations in glioma.

Significance of TERT and ATRX mutations in glioma.

Journal: Oncology letters

Published: December 02, 2017

Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.

Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.

Journal: Clinical neurology and neurosurgery

Published: November 21, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026